Amylin-like Drugs as a New Major Option for Weight Loss: Review of Lab and Early Human Studies

Incretin-based therapies have transformed obesity management, but additional strategies are needed.

• The biological complexity of obesity presents challenges that require innovative treatment approaches.
• Amylin, a hormone produced by the pancreas, plays a role in regulating appetite and glucose metabolism.
• Emerging evidence suggests that amylin-based therapies could offer new options in managing obesity.
• This review discusses the physiological functions of amylin and its potential impact on obesity treatment.

Simplified